Drug product
Hydroxyprogesterone 250 mg/mL Injectable, 4 mL, 6 mL,8 mL and 10 mL vials, compounded by The Compounding Shop, St. Petersburg, FL
D-556-2013
Product summary
- Event
- Event 65125
- Status
- Terminated
- Classification
- Class II
- Quantity
- 12 vials of 4mL, 1 vial of 6 mL, 1 vial of 8 mLand 3 vials of 10mL
- Official record key
drug-enforcement:D-556-2013
Official wording
Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Code information: All Lots
Distribution pattern: Florida, California, Minnesota, and Maine
Derived failure modes
-
Sterility assurance
Lack of Assurance of Sterility